CN Patent

CN115397398A — 环状酯肽的局部药物制剂

Assigned to Shengmai Pharmaceutical Co ltd · Expires 2022-11-25 · 3y expired

What this patent protects

本文公开了适用于局部施用的式(I)的化合物(LM030)的药物组合物。所述化合物可以为溶解形式，与增溶剂以及一种或多种药用赋形剂一起配制。

USPTO Abstract

本文公开了适用于局部施用的式(I)的化合物(LM030)的药物组合物。所述化合物可以为溶解形式，与增溶剂以及一种或多种药用赋形剂一起配制。

Drugs covered by this patent

halobetasol-propionate (HALOBETASOL PROPIONATE)

Patent Metadata

Patent number: CN115397398A
Jurisdiction: CN
Classification: —
Expires: 2022-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Shengmai Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.